Standout Papers

The Disposal of an Oral Glucose Load in Healthy Subjects: A Quantitative Study 1985 2026 1998 2012 324
  1. The Disposal of an Oral Glucose Load in Healthy Subjects: A Quantitative Study (1985)
    Eleuterio Ferrannini, Ola Björkman et al. Diabetes

Citation Impact

Citing Papers

Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)
2001 StandoutScience
Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure
1998
Pathogenesis of type 2 diabetes mellitus
2004
Thiazolidinediones
2004 Standout
Developmental neurotoxicity of industrial chemicals
2006 Standout
Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine
1995 Standout
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats.
1995
Influence of Ethnicity and Familial Diabetes on Glucose Tolerance and Insulin Action: A Physiological Analysis
2003
The paradox of low BNP levels in obesity
2011
Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects.
1995
Use of organic cosmotropic solutes to crystallize flexible proteins: application to T7 RNA polymerase and its complex with the inhibitor T7 lysozyme
1997 StandoutNobel
Inhibitory action of insulin‐sensitizing agents on calcium channels in smooth muscle cells from resistance arteries of guinea‐pig
1998
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
2006 StandoutNature
Pathophysiology of Prediabetes
2011
Analytical and clinical evaluation of TSH and thyroid hormones by electrochemiluminescent immunoassays
1999
The metabolic syndrome
2010 Standout
Metabolic Effects of Visceral Fat Accumulation in Type 2 Diabetes
2002
Uric Acid and Cardiovascular Risk
2008 Standout
GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects
2010 Standout
Gout
2009 Standout
Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).
1997
A systematic review of foot ulcer in patients with Type 2 diabetes mellitus. I: prevention
1999
Inflammation and insulin resistance
2006 Standout
Comparison of the glucose oxidase method for glucose determination by manual assay and automated analyzer
2000
Patterned Paper as a Platform for Inexpensive, Low‐Volume, Portable Bioassays
2007 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
The importance of selenium to human health
2000 Standout
The metabolic syndrome
2005 Standout
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
2006 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Graft-versus-host disease
2009 Standout
Gout
2016 Standout
Diabetic foot ulcers
2003 Standout
Microalbuminuria and Endothelial Dysfunction: Emerging Targets for Primary Prevention of End-organ Damage
2006
Type 1 diabetes
2013 Standout
Subclinical Thyroid Disease
2004 Standout
Inflammation in atherosclerosis
2002 StandoutNature
RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease
2002
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals
2001 Standout
Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats.
1990
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
2005 Standout
Usefulness of Microalbuminuria in Predicting Cardiovascular Mortality in Treated Hypertensive Men With and Without Diabetes Mellitus
1997
Contributions of  -Cell Dysfunction and Insulin Resistance to the Pathogenesis of Impaired Glucose Tolerance and Impaired Fasting Glucose
2006
Alterations in 3,3'5'-triiodothyronine metabolism in response to propylthiouracil, dexamethasone, and thyroxine administration in man.
1989
Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α
2006 Standout
Preventing Foot Ulcers in Patients With Diabetes
2005 Standout
Effect of urate‐lowering therapy on the velocity of size reduction of tophi in chronic gout
2002
Prediabetes: a high-risk state for diabetes development
2012 Standout
Obesity and insulin resistance
2000 Standout
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
2002 Standout
Splanchnic and renal metabolism of insulin in human subjects: a dose-response study
1983 Standout
Thyroid Hormones in Pregnancy in Relation to Environmental Exposure to Organochlorine Compounds and Mercury
2005
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults
2004 Standout
Ethanol-Induced Hyperuricemia
1982
Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans
2002 Standout
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults
2011 Standout
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
2009 Standout
Insulin Resistance in Essential Hypertension
1987 Standout
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases
2002 Standout
Advanced Glycation End Products
2006 Standout
Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption in Addition to Increasing Urinary Glucose Excretion
2013
Low Selenium Status in the Elderly Influences Thyroid Hormones
1995
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat.
1996
Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: Contributions of excessive hepatic glucose production and impaired tissue glucose uptake
1989
Effect of Pioglitazone on Abdominal Fat Distribution and Insulin Sensitivity in Type 2 Diabetic Patients
2002
Carbohydrate Metabolism in Non-Insulin-Dependent Diabetes Mellitus
1992
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Kinetics of glucose disposal in whole body and across the forearm in man.
1987
Dose-Response Effect of Pioglitazone on Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes
2002
High Glucose Concentrations Increase Endothelial Cell Permeability via Activation of Protein Kinase Cα
1997
Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.
1984
Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ
2001 StandoutScience
Changes in insulin action and GLUT-4 with 6 days of inactivity in endurance runners
1996
Indirect calorimetry: methodological and interpretative problems
1990
Inflammation and Atherosclerosis
2002 Standout
Electrochemiluminescence (ECL)
2004 Standout
Fluctuations of protein structure as expressed in the distribution of hydrogen exchange rate constants
1980
Regulation of hepatic glucose metabolism in humans
1987
Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans
1988
Activation of Receptor for Advanced Glycation End Products
1999
Elevated Triglycerides Correlate With Progression of Diabetic Neuropathy
2009
Interaction of carnitine with insulin-stimulated glucose metabolism in humans
1988
Role of Insulin Resistance in Human Disease
1988 Standout
Physical training and insulin sensitivity
1986
Use of a variable tracer infusion method to determine glucose turnover in humans
1990
Effects of caloric deprivation on thyroid hormone tissue uptake and generation of low-T3 syndrome
1986
CHARACTERISTICS OF PATIENTS WITH NORMAL T3 AND T4 AND A LOW TSH RESPONSE TO TRH
1986
The Significance of Impaired Fasting Glucose Versus Impaired Glucose Tolerance
2003
Pathophysiology and Pharmacological Treatment of Insulin Resistance*
2000
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.
2000
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
2016
Effect of insulin on uric acid excretion in humans
1995

Works of A Pilo being referenced

Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study
2009
A New Chemiluminescence Immunoassay for Triiodothyronine and Thyroxine: Evaluation Using Quality Control Sera Assayed in an Interlaboratory Survey
1990
Progress Report of an External Quality Assessment Scheme for Cyclosporine Assay
1996
In vivo measurement of ANP overall turnover and identification of its main metabolic pathways under steady state conditions in humans
1995
Systematic differences between commercial immunoassays for free thyroxine and free triiodothyronine in an external quality assessment program.
1994
The Disposal of an Oral Glucose Load in Healthy Subjects: A Quantitative Study
1985 Standout
Triiodothyronine turnover studies in euthyroid patients with autonomous thyroid nodules
1979
Uric acid metabolism in normal subjects and in gouty patients by chromatographic measurement of 14C-uric acid in plasma and urine
1979
Insulin Kinetics and Glucose-Induced Insulin Delivery in Chronically Dialyzed Subjects: Acute Effects of Dialysis*
1979
Increased Transcapillary Escape Rate of Albumin in Microalbuminuric Type II Diabetic Patients
1995
Thyroidal and peripheral production of 3,5,3'-triiodothyronine in humans by multicompartmental analysis
1990
Insulin kinetics after portal and peripheral injection of [125I] insulin: II. Experiments in the intact dog
1976
Altered Tissue Degradation and Distribution of Atrial Natriuretic Peptide in Patients With Idiopathic Dilated Cardiomyopathy and Its Relationship With Clinical Severity of the Disease and Sodium Handling
1995
Four methods for glucose assay compared for various glucose concentrations and under different clinical conditions.
1982
Insulin kinetics after portal and peripheral injection of [125I] insulin. I. Data analysis and modeling
1976
ANP kinetics in normal men: in vivo measurement by a tracer method and correlation with sodium intake
1993
Effect of insulin on the distribution and disposition of glucose in man.
1985
A computer program for multiexponential fitting by the peeling method
1970
Kinetic Analysis of Plasma Insulin Disappearance in Nonketotic Diabetic Patients and in Normal Subjects
1978
Evaluation of Triiodothyronine (T3) Kinetics in Normal Subjects, in Hypothyroid, and Hyperthyroid Patients Using Specific Antiserum for the Determination of Labeled T3in Plasma
1978
Rankless by CCL
2026